Classification of Non-Small Cell Lung Cancer’s Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade

SIMPLE SUMMARY: Immune checkpoint blockade (ICB) has become a major treatment for lung cancer. Better understanding of the tumor immune micro-environment (TIME) in non-small cell lung cancer (NSCLC) is urgently needed to better treat it with this type of therapy. In this review, we describe and expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Alexander, He, Xia, Hou, Lin, Nguyen, Nam P., Zhu, Guangying, Cameron, Robert B., Lee, Jay M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230820/
https://www.ncbi.nlm.nih.gov/pubmed/34208113
http://dx.doi.org/10.3390/cancers13122924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230820/
https://www.ncbi.nlm.nih.gov/pubmed/34208113
http://dx.doi.org/10.3390/cancers13122924

Ejemplares similares